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Abstract 
Background: This study reviewed the clinical presentation, cytologic findings and the 
immunophenotype of 69 Merkel Cell Carcinoma (MCC) cases sampled by FNA. 
Methods: Demographic and clinical data, the cytology findings and results of ancillary testing were 
reviewed.  
Results: Median patient age was 78 years (37 – 104) with a 1:1.8 female to male ratio. The most 
common FNA sites sampled included lymph nodes in the neck, the axillary region, the inguinal region 
and the  parotid gland. Most patients had a history of MCC (68%) &/or non-MCC malignancy (70%).  
The common cytologic pattern was a cellular smear with malignant cells arranged in a dispersed 
pattern with variable numbers of disorganised groups of cells. Cytoplasm was scant or absent and 
nuclei showed mild to moderate anisokaryosis, stippled chromatin, inconspicuous nucleoli and 
nuclear molding. Numerous apoptotic bodies were often present. 
Cell block samples (28 cases) were usually positive for cytokeratins in a perinuclear dot pattern, 
including 88% of cases with CK20 positivity. CD56 was the most sensitive (95%) neuroendocrine 
marker on cell blocks and was also positive with flow cytometry in 9 cases tested. 
Conclusions: MCC is most commonly seen in FNA specimens from the head and neck of elderly 
patients, often with a history of previous skin lesions. Occasional cases present in younger patients 
and some may be mistaken for other round blue cell tumors, such as lymphoma. CD 56 may be a 
useful marker in cell block preparations and in flow cytometric analysis of MCC. 
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Introduction 
Merkel cell carcinoma (MCC) is a rare aggressive neuroendocrine tumor of skin that commonly 
metastasises to lymph nodes and may be a target for fine needle aspiration (FNA). The tumor occurs 
primarily in elderly Caucasian patients and is more common in immunosuppressed individuals1. It 
also occurs relatively commonly in patients with a history of another neoplasm. Clinically, MCC 
usually appears as a small red-purple hard nodule, most often on sun exposed areas such as the head, 
neck or extremities, and is often indistinguishable from other skin cancers1. It carries a poor 
prognosis, with mortality rates exceeding those of melanoma. Metastases to local lymph nodes occurs 
in about 2/3 of patients and distant metastases and death in about 1/31. In 10-20% of cases with 
metastatic disease the primary tumor is not identified2, possibly due to spontaneous regression of the 
cutaneous primary in some cases3.  
Most published studies of the cytologic findings of MCC are single case reports or small series. 
Queensland, 'the Sunshine State’ of Australia, has high rates of skin cancer and MCC is not 
uncommonly encountered in our FNA practice. Although most cases have a characteristic 
morphology and a known history, the diagnosis of MCC can be problematic when other small cell 
tumors are a consideration in the differential diagnosis, and particularly when a primary tumor has not 
been identified or the clinical history is not typical. We reviewed the clinical and cytological 
presentation and the immunophenotype of a large series of confirmed MCC cases reported on FNA to 
highlight the potential pitfalls posed by MCC in FNA specimens. 
 
Methods 
 Sixty-nine FNA cases from 64 patients reported as suspicious for or consistent with Merkel Cell 
Carcinoma (MCC) over an 8 year period were reviewed. All cases had a clinical history of MCC 
provided and/or had a histologic report of MCC on file or had subsequent histologic confirmation.  
Demographic and clinical data were collated and the slides were reviewed to summarize cytologic 
features. Five cases were prepared as air-dried Romanowsky stained smears only and in 64 cases 
fixed Papanicolaou stained smears were also available. Results of ancillary testing performed on 
needle rinses were also summarised.  
 
Results:  
Patient age ranged from 37 to 104 years (median age 78) with a 1:1.8 female to male ratio. Only four 
(6%) patients were aged less than 60 years. The specimens were collected from a range of sites (Table 
1). Most were in the head/neck region, particularly lymph nodes in the cervical region (30 cases; 
43.5%), the parotid gland (8; 11%) or other  lymph nodes in the axillary (20%) or inguinal region 
(11%). Metastatic lesions in the pancreas (2) and breast (1) were also reported. Three (4%) of the 
lesions sampled were primary cutaneous tumors. Most patients (45/64; 70%) had a history of non-
MCC neoplasm: SCC (33; 48%), BCC (33; 48%), melanoma in 7 cases (10%), and in two cases NHL 
(3%). A history of multiple neoplastic skin lesion biopsies was present in 68% (44/64). 
The most frequently observed cytologic features are summarised in Table 2. The common cytologic 
pattern was a highly cellular smear in which malignant cells predominated. The cells were usually 
arranged in a dispersed pattern with most cases (88%) also showing at least some cohesive 
disorganised groups of cells. Cell grouping was, however, highly variable, with some cases presenting 
in a totally dispersed, lymphoma-like, pattern (Fig. 1) while a few cases were composed 
predominantly of loosely cohesive malignant cells (Fig. 2). A careful search was required in some 
cases to identify small cell groups composed of tightly packed molded nuclei with little or no 
cytoplasm (Fig. 3). Single cells were usually stripped of cytoplasm but, when present, it was delicate 
and pale with ill-defined cell borders (Fig. 4). Cytoplasmic intermediate filament buttons, as described 
by some authors4 were noted in only 3/69 (4%) of cases. Nuclei showed mild to moderate 
anisokaryosis, stippled chromatin and inconspicuous nucleoli. Nuclear molding was usually focally 
apparent (Fig. 5). Two cases contained malignant cells with marked anisokaryosis and some cells with 
enlarged nuclei with irregular nuclear membranes. Numerous apoptotic bodies were present in 60% of 
cases (Fig. 6) but necrosis was rarely seen (13%).  Lymphoglandular bodies were identified in two 
cases (3%) only, both of which contained moderate numbers of lymphocytes. Cell block samples were 
immunostained in 28 cases using a variety of stain panels. Results are summarised in Table 3. Most 
cases tested showed perinuclear dot positivity for cytokeratins, with 88% (22/28) positive for CK20 
(Fig. 7). CD56 was the most sensitive neuroendocrine marker for MCC, with positive staining in 
20/21 (95%) cell block cases (Fig. 8). CD56 was also detected by flow cytometry in 9/9 cases, giving 
an overall sensitivity of 97% (29/30). 
 
Discussion 
 Data from the US and Australia indicates that the  incidence of MCC is increasing.5,6 Factors 
implicated in the development of  MCC include infection with Merkel cell polyomavirus,7 
immunosuppression,8 sun exposure9 and altered function of tumor suppressor genes.10  
The tumor has a characteristic presentation in FNA and should be suspected when small round blue 
cell tumors are present in specimens collected from the head and neck of elderly patients, particularly 
those with a history of previous skin lesions. Almost 70% of cases in this series had a history of MCC 
provided. A similar proportion had a history of other malignancy, including prior melanoma in 10% 
of patients and one patient each with B-cell lymphoma and chronic lymphocytic leukemia (CLL). 
MCC often occurs in patients with another neoplasm, most frequently with SCC, CLL or B-cell 
lymphoma.2,11 This may complicate the FNA diagnosis, particularly as some of the cases reviewed 
showed a primarily dispersed population of small to medium sized malignant cells with only mild 
anisokaryosis.  
Lymphoid cells pose the most common differential diagnosis for MCC in FNA. Lymph nodes are the 
most common site in which MCC is sampled by FNA and the malignant cells may be misinterpreted 
as benign or malignant lymphoid cells. A dispersed population of malignant cells with mild 
anisokaryosis may be overlooked in a lymphoid-rich background. Alternatively, MCC may be 
mistaken for lymphoma.2 In the current series an initial impression of lymphoma led to the 
performance of cell surface markers by flow cytometry rather than cell block preparation. In these 
cases, as others have reported,12 we have found CD56 to be a valuable marker that works well with 
flow cytometry and is a useful addition to the surface marker panel if the predominant cell population 
is found to be CD45 negative. It must remembered however that some T-cell lymphomas express 
CD5613 and that plasma cell neoplasms may be CD45- / CD56+. Table 4 lists the morphologic 
features that are useful in discriminating MCC from lymphoma. The use of both Romanowsky and 
Papanicolaou stains on cytology smears is valuable as they highlight different features: 
lymphoglandular bodies and nuclear molding are best appreciated on the former, while the stippled 
chromatin pattern and the presence and size of nucleoli are more obvious on Pap stained smears. An 
absence of lymphoglandular bodies is a useful feature of MCC, however assessment of their presence 
is difficult when abundant necrotic material is present and they may be present in smears containing 
benign lymphocytes. 
Cytoplasmic and free intermediate filament buttons, so-called ‘blue blobs’ have been described as a 
feature of MCC,4 however although cytokeratin perinuclear dot positivity was seen with IHC, we 
found it uncommon in conventional cytology stains. Several studies of MCC have not identified this 
feature and it has been suggested they are more commonly seen in haematoxylin and eosin stained 
specimens.14 
Small cell carcinoma, metastatic from both lung and non-pulmonary sites, may also enter into the 
differential diagnosis. Morphologically MCC is less likely to show marked anisokaryosis (only 7% in 
this series) and necrosis (13%). Clinical history and immunohistochemistry may also be helpful. 
Small cell carcinoma, both lung and non-pulmonary, usually express TTF1 and rarely express 
CK20.15,16 Cytogenetic anlaysis for trisomy of  chromosome 6 & 8, using FISH on cytology slides, 
rarely present in SCLC but common in MCC, may also assist.17 Small cell carcinoma of salivary 
gland, a rare neoplasm,  is virtually indistinguishable from metastatic MCC if a primary tumor is not 
identified, showing a similar morphology and immunophenotype. Eight cases in the current series 
were metastatic MCC presenting as parotid lesions from primary tumors mostly on the face (7/8). 
 
Basaloid tumors must also be excluded, particularly in head and neck sites. Basal cell carcinoma 
typically presents as cohesive groups of uniform cells, sometimes with pallisading. Pilomatrixoma is 
another consideration, particularly as it may be mistaken clinically for a lymph node in the head/neck 
region. It usually occurs in younger patients and also usually contains squamous cells, ghost cells and 
multinucleate histiocytes. A range of salivary gland neoplasms may also have a basaloid pattern on 
FNA,18 however the cells from these lesions generally show more cohesion, less anisokaryosis, 
nuclear molding and lack the stippled chromatin of MCC. In addition, other features such as 
metachromatic stromal elements may help in identifying salivary gland neoplasms. A history of 
melanoma was not uncommon in this series, occurring in 10% of cases. It is notoriously varied in 
appearance and may present as a small round cell tumor. Nucleoli are usually prominent in melanoma 
but IHC may be very helpful in these cases.  Although melanoma may express CD56,13 MCC is 
usually cytokertain positive and negative for melanoma markers.  
In summary MCC is a rare but increasingly encountered tumor that may be reliably diagnosed by 
FNA if the  clinical, morphologic and immunophenotypic information is avaliable. FNA may be a 
useful diagnostic modality to confirm metastasis, aid with treatment planning and exclude other 
tumors and conditions. 
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 Fig. 1.  Lymphoma-like presentation of dispersed malignant cells with little or no cytoplasm. (FNA 
Axilla; Quick Dip stain;  x100). 
Fig. 2. Malignant cells predominantly arranged in cohesive disorganised groups. (FNA neck lymph 
node; Papanicolaou stain; x100). 
Fig. 3. Tight group of molded nuclei with little or no cytoplasm. (FNA groin lymph node; 
Papanicolaou stain; x400). 
Fig. 4. Malignant cells with finely stippled chromatin and delicate cytoplasm. (FNA neck lymph node; 
Papanicolaou stain; x400). 
Fig. 5. Malignant cells with scant cytoplasm and nuclear molding. (FNA groin lymph node; Quick 
Dip stain; x400). 
Fig. 6.  Malignant cells with numerous apoptotic bodies. (FNA neck lymph node; Papanicolaou stain; 
x200). 
Fig. 7.  Cell block preparation showing perinuclear dot positivity for Cytoketarin 20. (FNA neck 
lymph node; Haematoxylin counterstain;  x400). 
Fig. 8.  Cell block preparation showing membrane staining with CD56. (FNA axilla; Haematoxylin 
counterstain; x400). 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Sites of FNA for the 69 cases of Merkel cell carcinoma reviewed. LN= lymph node. 
Site N %
Lymph node, cervical 30 43.5
Lymph node, axillary region 14 20.3
Parotid gland 9 11.6
Lymph node, inguinal region 8 11.6
Upper arm 2 2.9
Pancreas 2 2.9
Lymph node, celiac 1 1.4
Breast 1 1.4
Chest 1 1.4
Thigh 1 1.4
 
   
Table 2. Most common cytomorphologic features observed in 69 FNA cases of 
Merkel Cell Carcinoma. 
 
Cytological Feature %
Moderate to high cellularity 98
Nuclear molding 96
Stippled chromatin on Pap 95
Inconspicuous nucleoli 94
Mild to moderate anisokaryosis 93
Mainly dispersed 89
Cohesive groups 59
Apoptotic bodies 62
Necrotic debris 13
 
 
 
   
Table 3. Immunohistochemical staining results on cell blocks prepared from 
FNA specimens of Merkel Cell Carcinoma.  
Stain N % +ve 
Cytokeratins   
   CK20 28 88% 
   Cam 5.2 17 94% 
   AE1/AE3 10 100% 
   MNF113 6 83% 
Neuroendocrine markers   
   CD56 21 95%* 
   Synaptophysin 13 84% 
   Chromogranin A 11 36% 
Melanoma markers   
   S100 9 0% 
   HMB45 5 0% 
   Melan A 5 0% 
CD45 12 0%** 
 
*An additional 9/9 cases positive for CD56 with flow cytometry. 
**An additional 9/9 cases negative for CD45 by flow cytometry. 
 
 
  
Table 4. Cytomorphologic features of value in discriminating Merkel Cell Carcinoma from lymphoma. 
 
Feature Merkel Cell Carcinoma Lymphoid cells/lymphoma 
Arrangement Variable but often at least some small cohesive 
groups 
Dispersed 
Lymphoglandular 
bodies 
Only if significant lymphoid population present Usually common 
Apoptosis Often present Variable, often absent 
Cytoplasm Absent or minimal; delicate, pale and ill-
defined 
Thin rim, cyanophilic 
Nuclei Usually mild to moderate anisokaryosis Usually mild anisokaryosis 
Nucleoli Absent/Inconspicuous & small Variable; may be 
prominent 
Chromatin Fine, stippled ‘chunky’ 
Nuclear molding Usually at least some present Usually absent 
  
 
 
